Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H27ClN4O |
| Molecular Weight | 446.972 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCN1CCN(CC2=CC=C(C=C2)C3=CC4=C(NC=C4C5=CC=CC(Cl)=C5)N=C3)CC1
InChI
InChIKey=VZJUKEQMHBEIKH-UHFFFAOYSA-N
InChI=1S/C26H27ClN4O/c27-23-3-1-2-21(14-23)25-17-29-26-24(25)15-22(16-28-26)20-6-4-19(5-7-20)18-31-10-8-30(9-11-31)12-13-32/h1-7,14-17,32H,8-13,18H2,(H,28,29)
| Molecular Formula | C26H27ClN4O |
| Molecular Weight | 446.972 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 11:51:57 GMT 2025
by
admin
on
Wed Apr 02 11:51:57 GMT 2025
|
| Record UNII |
WJP32276AY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
754220
Created by
admin on Wed Apr 02 11:51:57 GMT 2025 , Edited by admin on Wed Apr 02 11:51:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2375591-69-6
Created by
admin on Wed Apr 02 11:51:57 GMT 2025 , Edited by admin on Wed Apr 02 11:51:57 GMT 2025
|
PRIMARY | |||
|
13464
Created by
admin on Wed Apr 02 11:51:57 GMT 2025 , Edited by admin on Wed Apr 02 11:51:57 GMT 2025
|
PRIMARY | |||
|
WJP32276AY
Created by
admin on Wed Apr 02 11:51:57 GMT 2025 , Edited by admin on Wed Apr 02 11:51:57 GMT 2025
|
PRIMARY | |||
|
154677753
Created by
admin on Wed Apr 02 11:51:57 GMT 2025 , Edited by admin on Wed Apr 02 11:51:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
serine/threonine kinase inhibitor, amyotrophic lateral sclerosis
|